Last updated on August 17, 2026 · Originally published February 19, 2023
Raw THCA does not produce a THC high. Smoke or vaporize it and heat converts it into THC, which does. Most people asking about the side effects of THCA flower are therefore asking about THC without realizing it.
Fresh high-THC cannabis contains most of its potential THC as THCA. The acid form carries an extra carboxyl group, which changes how it binds and where it travels in the body. THCA has much weaker activity at CB1 than THC and showed much poorer brain penetration in animal pharmacokinetic studies, which helps explain why it does not produce the same intoxication.
That difference is why the side effects question has two answers, and why the answer you need depends on whether heat has been applied.
Does raw THCA get you high?
In its unheated form, THCA does not produce the intoxication associated with THC.
Eating or juicing genuinely unheated cannabis delivers mostly THCA, although fresh material already contains some THC and further conversion can occur during drying, extraction and storage. A tincture described as cold-processed is not necessarily THC-free.
What are the side effects of raw THCA?
We do not have a reliable list.
THCA itself has not been characterized in controlled human safety studies. Consumer reports cannot separate the effects of THCA from the THC already present in a product or produced during processing and storage.
That means there is no established safe dose, no reliable estimate of how commonly side effects occur, and almost no long-term safety information. The absence of documented side effects is not evidence of safety; it is mostly evidence of how little THCA has been studied in people.
What happens when THCA is heated?
Heat drives the carboxyl group off as carbon dioxide and converts THCA into THC, a reaction called decarboxylation — covered in detail in our guide to what heat converts and what it costs.
It does not take much. Smoking or vaporizing does it almost instantly, baking does it over minutes, and even prolonged storage converts a slow trickle without any deliberate heating. The conversion is not one-for-one by weight, since the molecule sheds mass as carbon dioxide: a gram of THCA yields roughly 0.877 grams of THC at complete conversion.
Once it has converted, the relevant psychoactive side effects are THC’s — dry mouth, red eyes, raised heart rate, impaired coordination and short-term memory, and at higher doses anxiety, paranoia or panic. Impairment affects driving, and regular heavy use carries the usual risks of regular heavy THC use.
This matters because THCA flower is often marketed in terms implying something gentler than cannabis. Once smoked or vaporized, it is not inherently gentler than conventional cannabis. The label describes what was in the jar, not what reaches the lungs. Whether the flower was sold federally as hemp does not change that chemistry.
Will THCA cause a positive drug test?
THCA products can produce a positive result, and this is the consequence people most often miss.
Standard urine screens look principally for THC-COOH, a metabolite of THC. Smoking, vaporizing or cooking a THCA product converts it into THC and can produce the same metabolites as conventional cannabis. Unheated products are not a dependable workaround either: they may already contain THC and can partially decarboxylate during manufacture and storage.
Federal legality at the point of sale is irrelevant here. A drug test measures metabolites, not compliance status.
What the research does and does not show
Several therapeutic claims attach to THCA, and each deserves reporting at its actual evidence level.
The preclinical work is real. THCA reduced nausea-related behavior in rats and shrews, showed anti-inflammatory activity in colon models, and acts as a PPARγ agonist with neuroprotective activity in laboratory models. These are legitimate findings and a reasonable basis for further study.
None is a clinical trial. No controlled human study supports THCA as a treatment for any condition, and preclinical activity frequently fails to replicate in people.
Claims that THCA has been shown to treat cancer, Parkinson’s disease, Alzheimer’s disease or multiple sclerosis in people are unsupported. Some laboratory and animal studies touch on mechanisms relevant to these conditions, but that is not clinical treatment evidence.
One miscitation is worth naming, because it circulates widely. A 2022 paper in Oncology Letters on the gene MAPK12 is sometimes cited as evidence that THCA shrinks tumors. In that paper THCA is an abbreviation for thyroid carcinoma, the standard code used in cancer genomics. Cannabis is never mentioned, and the study’s actual finding is that the gene promotes tumor cell proliferation.
For the chemistry of the compound and how it behaves under heat, see how THCA diamonds form and our piece on cannabinoid boiling points.
References
- McPartland JM, MacDonald C, Young M, Grant PS, Furkert DP, Glass M. Affinity and efficacy studies of tetrahydrocannabinolic acid A at cannabinoid receptor types one and two. Cannabis and Cannabinoid Research. 2017;2(1):87-95. doi:10.1089/can.2016.0032
- Wang M, Wang YH, Avula B, et al. Decarboxylation study of acidic cannabinoids: a novel approach using ultra-high-performance supercritical fluid chromatography/photodiode array-mass spectrometry. Cannabis and Cannabinoid Research. 2016;1(1):262-271. doi:10.1089/can.2016.0020
- Rock EM, Kopstick RL, Limebeer CL, Parker LA. Tetrahydrocannabinolic acid reduces nausea-induced conditioned gaping in rats and vomiting in Suncus murinus. British Journal of Pharmacology. 2013;170(3):641-648. doi:10.1111/bph.12316
- Nallathambi R, Mazuz M, Ion A, et al. Anti-inflammatory activity in colon models is derived from Δ9-tetrahydrocannabinolic acid that interacts with additional compounds in cannabis extracts. Cannabis and Cannabinoid Research. 2017;2(1):167-182. doi:10.1089/can.2017.0027
- Nadal X, del Río C, Casano S, et al. Tetrahydrocannabinolic acid is a potent PPARγ agonist with neuroprotective activity. British Journal of Pharmacology. 2017;174(23):4263-4276. doi:10.1111/bph.14019
Originally published February 19, 2023. Updated August 17, 2026 to add the raw-versus-heated distinction and decarboxylation, and drug testing; and to remove therapeutic claims that were not supported by the sources cited for them.
Reviewed by Nani Frenkel, chief editor.
This article is for information only. It is not medical advice.
